Renaissance Technologies - AIM IMMUNOTECH INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q3 2023$88
-26.7%
192,308
+7.5%
0.00%
Q2 2023$120
+64.4%
178,808
+6.0%
0.00%
Q1 2023$73
+69.8%
168,708
+23.2%
0.00%
Q4 2022$43
-99.9%
136,908
+9.6%
0.00%
Q3 2022$73,000
-22.3%
124,908
+3.7%
0.00%
Q2 2022$94,000
-79.3%
120,408
-71.9%
0.00%
-100.0%
Q1 2022$454,000
-30.0%
428,071
-39.3%
0.00%0.0%
Q4 2021$649,000
+97.3%
705,100
+361.3%
0.00%
Q2 2021$329,000
-69.7%
152,848
-68.1%
0.00%
-100.0%
Q1 2021$1,087,000
+11977.8%
478,759
+2667.4%
0.00%
Q4 2019$9,00017,3000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
ForthRight Wealth Management, LLC 20,000$13,4000.01%
SeaCrest Wealth Management, LLC 37,063$24,8320.00%
D.B. Root & Company, LLC 12,050$8,0740.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 108,900$72,9630.00%
Traynor Capital Management, Inc. 11,777$7,8910.00%
Community Bank, N.A. 13,226$8,8610.00%
Verition Fund Management LLC 140,000$93,8000.00%
DRW Securities, LLC 37,000$250.00%
SNS Financial Group, LLC 10,000$6,7000.00%
HUNTINGTON NATIONAL BANK 57$380.00%
View complete list of AIM IMMUNOTECH INC shareholders